Pd Rx Pharmaceutical Stock Price Prediction
| PDRX Stock | USD 3.33 0.00 0.00% |
Momentum 83
Buy Peaked
Oversold | Overbought |
Using Pd Rx hype-based prediction, you can estimate the value of Pd Rx Pharmaceutical from the perspective of Pd Rx response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pd Rx to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying PDRX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pd Rx after-hype prediction price | USD 3.32 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
PDRX |
Pd Rx After-Hype Price Prediction Density Analysis
As far as predicting the price of Pd Rx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pd Rx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Pd Rx, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pd Rx Estimiated After-Hype Price Volatility
In the context of predicting Pd Rx's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pd Rx's historical news coverage. Pd Rx's after-hype downside and upside margins for the prediction period are 1.38 and 5.26, respectively. We have considered Pd Rx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pd Rx is slightly risky at this time. Analysis and calculation of next after-hype price of Pd Rx Pharmaceutical is based on 3 months time horizon.
Pd Rx Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pd Rx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pd Rx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pd Rx, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.24 | 1.94 | 0.01 | 0.00 | 6 Events / Month | 2 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.33 | 3.32 | 0.30 |
|
Pd Rx Hype Timeline
Pd Rx Pharmaceutical is at this time traded for 3.33. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. PDRX is projected to decline in value after the next headline, with the price expected to drop to 3.32. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.3%, whereas the daily expected return is at this time at 0.24%. The volatility of related hype on Pd Rx is about 16166.67%, with the expected price after the next announcement by competition of 3.33. The company last dividend was issued on the 13th of December 2018. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Pd Rx Basic Forecasting Models to cross-verify your projections.Pd Rx Related Hype Analysis
Having access to credible news sources related to Pd Rx's direct competition is more important than ever and may enhance your ability to predict Pd Rx's future price movements. Getting to know how Pd Rx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pd Rx may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KOSK | One Step Vending | 0.00 | 0 per month | 12.28 | 0 | 22.67 | (26.92) | 70.33 | |
| FZMD | Fuse Medical | (0.04) | 12 per month | 0.00 | 0.11 | 25.00 | (20.00) | 321.43 | |
| RMSL | REMSleep Holdings | 0.00 | 0 per month | 7.33 | 0.11 | 23.81 | (18.75) | 278.33 | |
| SEHCF | Sweet Earth Holdings | (0.04) | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SRNE | Sorrento Therape | (0.04) | 3 per month | 18.47 | 0.07 | 39.53 | (33.85) | 195.71 | |
| RNVA | Rennova Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CPIVF | Captiva Verde Land | 0.00 | 0 per month | 25.40 | 0.23 | 127.27 | (58.95) | 216.41 | |
| IDXG | Interpace Biosciences | 0.00 | 0 per month | 5.16 | 0.13 | 17.14 | (10.45) | 45.43 | |
| RPNRF | Rapid Nutrition PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MVMDF | Mountain Valley MD | 0.00 | 0 per month | 10.69 | 0.07 | 27.00 | (21.80) | 86.13 |
Pd Rx Additional Predictive Modules
Most predictive techniques to examine PDRX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PDRX using various technical indicators. When you analyze PDRX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pd Rx Predictive Indicators
The successful prediction of Pd Rx stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pd Rx Pharmaceutical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pd Rx based on analysis of Pd Rx hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pd Rx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pd Rx's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PDRX Pink Sheet Analysis
When running Pd Rx's price analysis, check to measure Pd Rx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd Rx is operating at the current time. Most of Pd Rx's value examination focuses on studying past and present price action to predict the probability of Pd Rx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd Rx's price. Additionally, you may evaluate how the addition of Pd Rx to your portfolios can decrease your overall portfolio volatility.